Regional Analysis

Global Inhalation Anesthesia Market: Regional Insights

Based on geography, the global inhalation anesthesia market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period owing to the increasing number of surgeries, increasing number of emergency incidences and road accidents, and growing geriatric population (susceptible to chronic disease) in the region. Aging is a strong risk factor for many chronic diseases. According to Centers for Disease Control and Prevention (CDC), chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the United States. Moreover, 6 in 10 Americans live with at least one chronic disease, such as heart disease and stroke, cancer, or diabetes.

Europe and Asia Pacific are also expected to witness significant growth in the global inhalation anesthesia market due to the rise in burden of chronic disease, growing geriatric population, rise in number of road accidents, and increasing number of surgical procedures in these regions. For instance, according to a repost published by Peertechz Publications, total 18882734 surgeries were carried out during 2019-20 in the public health facilities in India. Of them 4851788 and 14030946 were major and minor surgeries, respectively. Moreover, according to the European Union, around 1.12 million caesarean sections performed in the EU in 2020.

North America: U.S. and Canada

Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe

Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific

Latin America: Brazil, Argentina, Mexico, and Rest of Latin America

Middle East and Africa: GCC Countries, Israel, Rest of Middle East, South Africa, North Africa, and Central Africa

Inhalation Anesthesia Market Report Snapshots